Horus Pharma: Clinical Trials

6 trials sponsored by Horus Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 5 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Unknown 2
Phase 11Completed 1

Follow Horus Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness
DM-28 - Dry Eye
Not applicableCompletedHorus Pharma442024-09-262025-02-13
Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness
DM934, Théalose - Dry Eye
Not applicableCompletedHorus Pharma852024-03-072025-02-13
Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction
Neovis Total Multi, Systane Balance - Dry Eye, Meibomian Gland Dysfunction
Not applicableUnknownHorus Pharma1202022-01-012022-01-13
Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands)
Barcimiant, Olumiant (first dose), Olumiant (second dose) - Healthy
Phase 1CompletedGenuine Research Center, Egypt302021-05-052021-08-16
Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness
Vismed gel Multi 0.3% eye drops, Vismed Multi 0.18% eye drops - Dry Eye
Not applicableUnknownHorus Pharma802018-09-012018-08-24
Evaluation of the Efficacy and Safety of DM05 Versus Optive™ on the Treatment of Moderate to Severe Ocular Dryness
DM05 eye drops, Optive™ eye drops - Dry Eye
Not applicableCompletedHorus Pharma802016-12-012018-05-07

Conditions studied

Dry Eye Syndromes (5)  ·  Meibomian Gland Dysfunction (1)

Interventions

baricitinib (1)

Countries

Poland (2)  ·  Egypt (1)  ·  France (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Ewa Paw, MD (2)  ·  Ahmed Elshafeey, Ph.D. Pharma (1)  ·  Christophe Baudouin, Pr (1)  ·  Hoffart Louis (1)